Retraction Watch

Tracking retractions as a window into the scientific process

Fourth retraction appears for cancer researcher Anil Jaiswal

with 6 comments

cancer research 1113The hits keep coming for University of Maryland researcher Anil Jaiswal.

The latest retraction for the cell biologist is in Cancer Research, for a 2007 paper about ways in which the cell tries to protect the tumor suppressor p53. Like the first Jaiswal retraction we covered, the latest notice specifically taps figure duplication as the cause of death, “as a result of an error.” The other two retractions gave no explanation for the withdrawal.

Here’s the notice:

The authors wish to retract the article titled “NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53,” which was published in the June 1, 2007, issue of Cancer Research (1). As a result of an error, the p53 and NQO2 panels in Fig. 6A were reused from Fig. 3B of the article titled “Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis” by Iskander and colleagues (2).

Two of the four authors agreed to this Retraction. Attempts on the part of the journal office to contact Xing Gong and Labanyamoy Kole were unsuccessful.

Karim Iskander

Onyx Pharmaceuticals, Inc., Houston, Texas

Anil K. Jaiswal

Department of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland.

We’ve reached out to Jaiswal, the University of Maryland’s office of research integrity, and the journal, and will update if we hear back.

The paper has been cited 79 times, according to Google Scholar.